|
"Yao Yating over from the previous two years API Last year, both companies saw the light, now Artemisinin Very tight supply of bulk drugs. "Biti was days before general manager Lin Ting told reporters. Depleted inventory digestion By 2006 the impact of the national expansion humilis species after 2007, humilis grown into a low, output plummeted. Data show that in 2006, the National humilis planted area of 100 mu yield of 300 tons of artemisinin, the output is about 3 times the market demand, more than 5000 kilograms humilis no purchase price of artemisinin from more than 4000 yuan / kg fell to 1,600 yuan / kg. Novartis claims that year, inventory of artemisinin at least two years digest. At that time, a large three-odd manufacturers of artemisinin Pharmacy And communication and medicine warehouses filled with artemisinin. As the artemisinin market oversupply, prices plummeted, many companies and farmers can not promise to honor the price protection, so that farmers have been hit cultivation of plant humilis lost confidence. It is understood that in 2009 the National humilis planted area of only about 5 acres, a larger gap in the market, forcing many companies turn to buy raw material drug production wild humilis. Also, because last year's rainy south, whether wild or cultivated humilis humilis, artemisinin content was very low, only five thousandths of high content to 7 thousandths, which is usually the purchase price of each 1000 points 1 to 1.1. According to the Beijing plant extract industry information network for people Shuli introduction in 2009, China's artemisinin Export Channels only Novartis and India. It is said that Novartis orders in China last year, the purchase price of artemisinin 300 dollars / kg, while India is with the need to purchase, follow the market, the latter part of the purchase price may be higher than Novartis. This year is turning point Chongqing Youyang enriching technology companies Wang Meisheng Artemisia annua, said inflection point may occur this year humilis planted, cultivated area will increase, prices will rise. The basis that: ACT because of the current international market price reduction of public funds in place, demand the increase of artemisinin raw materials will increase the demand for drugs; year humilis planted, the final storage of artemisinin is difficult to harvest meet the market demand, there is notch; previous years, drug manufacturers of artemisinin raw material losses, need to rely on price increases to fill the shortfall; current farm prices generally continued to rise. Linting that, after the industry downturn in 2006, the current artemisinin-based drug company is running out of raw materials. And hurt the confidence of Artemisia farmers find it difficult to restore, simply very difficult to mobilize farmers to grow, despite the current artemisinin prices have gone up a lot, humilis supply, it is difficult to form the expanding trend, because both the enterprises and farmers, are very sensible of. Meanwhile, African countries and Vietnam humilis planted in 2009 is also very limited, almost no wild humilis, which increased the supply of artemisinin-market tension. Humilis in the Artemisia annua plant the most low-end chain, but is the industry's most critical link. Widely believed, this year will be a key year for industrial development of Artemisia annua, humilis plant can scientific and orderly, related to the industry's future. From the industry concerned, with the artemisinin prices, humilis in short supply, expansion of species, expansion of the wind will come back? Experts point out that hope that the enterprises can be rational in the face of this time, do not re-enter Enthusiasm for the "vicious circle." The e-commerce company in China offers quality products such as China Deep Groove Ball bearings , Thrust Ball Bearings, and more. For more , please visit Insert Bearing today!
Related Articles -
China Deep Groove Ball bearings, Thrust Ball Bearings,
|
